APA (7th ed.) Citation

SF, I., HM, L., T, L., K, J., AF, C., K, H., . . . P, J. (2020). Increased serum levels of microfibrillar-associated protein 4 (MFAP4) are not associated with clinical synovitis in rheumatoid arthritis but may reflect underlying cardiovascular comorbidity. Clinical and experimental rheumatology, 38(1), 122.

Chicago Style (17th ed.) Citation

SF, Issa, Lindegaard HM, Lorenzen T, Junker K, Christensen AF, Hørslev-Petersen K, Holmskov U, Sorensen GL, and Junker P. "Increased Serum Levels of Microfibrillar-associated Protein 4 (MFAP4) Are Not Associated with Clinical Synovitis in Rheumatoid Arthritis but May Reflect Underlying Cardiovascular Comorbidity." Clinical and Experimental Rheumatology 38, no. 1 (2020): 122.

MLA (9th ed.) Citation

SF, Issa, et al. "Increased Serum Levels of Microfibrillar-associated Protein 4 (MFAP4) Are Not Associated with Clinical Synovitis in Rheumatoid Arthritis but May Reflect Underlying Cardiovascular Comorbidity." Clinical and Experimental Rheumatology, vol. 38, no. 1, 2020, p. 122.